News
The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...
I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.
By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...
On November 14, 2024, the Company announced a poster presentation at the American College of Rheumatology Convergence 2024 Annual Meeting covering data from Eupraxia's Phase 2b SPRINGBOARD trial ...
One by one, at a Clearwater town hall on Saturday, Pinellas County constituents took turns addressing a "missing" poster of Rep. Ana Paulina Luna, R-Fla., expressing discontent with President ...
Logan • A northern Utah school district said it was committed to fostering an environment of inclusion after administrators removed two offensive student-created posters from a classroom earlier ...
Leader of Opposition Jai Ram Thakur says youth of neighboring states create ruckus in Himachal as they move around with posters of Bhindranwale on their vehicles Leader of Opposition Jai Ram ...
Gary Collins, Professor of Medical Statistics at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, and author of FUTURE-AI ...
At week 52, results showed AChR+ patients treated with inebilizumab continued to improve based on the change from baseline in MG-ADL score vs placebo. Treatment with inebilizumab was associated with ...
According to The London Economics, the last few weeks have seen the streets of London filled with posters that have been calling out Elon Musk. The billboards, which have been placed on Tube stations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results